Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidence
By relaxing immune tolerance, immune checkpoint inhibitors can restore antitumor responses but can also cause immune-related adverse events across multiple organs. Efficacy and toxicity occur together in some patients, yet this association does not mea…